Roundup manufacturer Monsanto, now owned by Bayer AG, recently submitted a comprehensive $7.25 billion tiered settlement proposal through the Circuit Court in St. Louis, Missouri. The agreement aims to resolve thousands of pending civil claims brought by individuals who allege that they developed cancer from exposure to glyphosate in Roundup. The filing represents one of the most substantial corporate settlement frameworks in recent product liability history, addressing both current claimants and those who may receive cancer diagnoses in coming years.
What the Proposed Roundup Settlement Means
The new settlement proposal, announced in February 2026, is designed to handle a large number of Roundup lawsuits in a more organized way. Instead of continuing to fight thousands of individual claims in court, Bayer is attempting to resolve them through one structured agreement. If approved, the Roundup settlement would allow eligible individuals to receive compensation without going through a full trial. This includes both people who used Roundup at home and those who were exposed to it through their jobs.
How the Tiered Payment System Works
A Long-Term Payment Plan
The total settlement amount of $7.25 billion would not be paid all at once. Instead, Bayer plans to spread payments out over roughly 17 to 21 years. Each year, money would be added to a settlement fund, which would then be used to pay claims. This approach allows the company to manage costs over time, while still setting aside money for future claimants.
How Compensation Is Calculated
Not everyone will receive the same amount in settlement funds. The settlement uses a points-based system to determine payouts for alleged Roundup-related injuries. Several factors can affect how much a person receives, including:
- The type and severity of the alleged illness
- How long the person was exposed to Roundup
- Whether the exposure happened at home or on the job
- The person’s age at the time of diagnosis
People with more serious conditions or longer exposure histories are likely to receive higher compensation.
Who May Be Included in the Roundup Settlement
Current Claimants
This group includes individuals who have already been diagnosed with cancer and have filed Roundup lawsuits. These claimants would be among the first to receive payments if the settlement is approved by the court.
Future Claimants
The proposed settlement also covers people who may develop cancer later. Some illnesses linked to chemical exposure can take years to appear, so the agreement includes a window, typically up to 16 years, for future diagnoses. This means someone who used Roundup years ago but has not yet become sick may still qualify for compensation later.
The Option to Opt Out of the Roundup Settlement
Participation in the Roundup settlement is not required. Individuals can choose to accept the agreement or they can “opt out” and continue with their own Roundup lawsuit. Accepting the settlement usually means faster payment and less stress. However, it may also mean receiving less than what could be awarded in a successful Roundup trial. Some plaintiffs have won large verdicts at trial, but others have lost. There is also a deadline to opt out, and missing that deadline typically means giving up the right to file an individual lawsuit.
Background on the Roundup Cancer Litigation
Product liability lawsuits alleging a link between Roundup and cancer began gaining attention around 2015. Plaintiffs claimed that exposure to glyphosate, the main ingredient in Roundup, caused certain types of cancer, particularly non-Hodgkin’s lymphoma. Since then, Roundup claims involving hundreds of thousands of plaintiffs have been filed in courts across the United States.
Previous Roundup Settlements and Trials
Bayer has already paid billions of dollars to settle earlier product liability claims. Some lawsuits have gone to trial, with mixed results. While several juries awarded large sums to plaintiffs, many of those awards were later reduced. Even after earlier settlements, thousands of Roundup cancer claims remain unresolved, which led to this new proposal.
A Separate Legal Battle at the Supreme Court
At the same time as the proposed Roundup settlement, Bayer is asking the U.S. Supreme Court to review an important legal issue. The company argues that federal law should prevent state-level claims about product warnings. If the Court agrees, it could limit future product liability lawsuits against Monsanto and Bayer. If not, similar claims may continue. Either way, the court’s decision could have a major impact on how these claims move forward.
What Happens Next?
This proposed settlement is an effort to resolve a long-running and complex legal fight involving Monsanto, Bayer, and their Roundup weed killer. However, before the proposed settlement takes effect, it must first be approved by the court. This process includes notifying potential claimants and holding a hearing to review whether the agreement is fair. If approved, the settlement will move forward. If not, the parties may need to revise the terms or return to court.
Roundup Lawsuit Information
Roundup Lawsuits, Leading Justice
Roundup Verdict: Bayer Ordered to Pay $175 Million in Latest Cancer Trial, Leading Justice
Bayer Allocates Another $1.37 Billion for Roundup Litigation, Leading Justice
Supreme Court to Decide Fate of Thousands of Roundup Cancer Lawsuits, Leading Justice
